MiNK Therapeutics, Inc.MiNK Therapeutics, Inc.MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc.

No trades
See on Supercharts

Price target

6.500.000.00%
The 2 analysts offering 1 year price forecasts for INKT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to INKT in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


INKT EPS for the last quarter is −0.05 USD despite the estimation of −0.08 USD. In the next quarter EPS is expected to reach −0.05 USD. Track more of MiNK Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter MiNK Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out MiNK Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, INKT price target is 6.50 USD with a max estimate of 9.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch MiNK Therapeutics, Inc. stock price chart and keep track of the current situation with INKT news and stock market news.